| 2025-12-15 |
详情>>
内部人交易：
Schaffer Ryan等共交易14笔
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本9303.89万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.15美元,归母净利润-1427.2万美元,同比去年增长-63.24%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘后发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-0.13美元,归母净利润-1195.7万美元,同比去年增长-82.69%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.03美元,归母净利润-316.9万美元,同比去年增长16.19%
|
| 2025-04-25 |
股东大会：
将于2025-06-13召开股东大会
会议内容 ▼▲
- 1.Election of the eight director nominees named in this Proxy Statement to serve on our Board of Directors until the 2026 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified. The Executive Committee of the Board of Directors (the “Executive Committee”) on behalf of the Board of Directors recommends a vote “FOR” each nominee.
2.Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2025. The Executive Committee on behalf of the Board of Directors recommends a vote “FOR” this proposal.
3.Approval, on an advisory basis, of the compensation of our named executive officers. The Executive Committee on behalf of the Board of Directors recommends a vote “FOR” this proposal.
4.Transaction of any other business which may properly come before the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) or any adjournment, continuation or postponement of the Annual Meeting.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-0.12美元,归母净利润-1005.5万美元,同比去年增长75.75%
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-0.33美元,归母净利润-2700.9万美元,同比去年增长-99.21%
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.1美元,归母净利润-874.3万美元,同比去年增长74.47%
|
| 2024-08-09 |
详情>>
业绩披露：
2023年中报每股收益-0.21美元,归母净利润-1724.9万美元,同比去年增长-12.23%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益-0.08美元,归母净利润-654.5万美元,同比去年增长62.06%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.04美元,归母净利润-378.1万美元,同比去年增长36.40%
|
| 2024-04-26 |
股东大会：
将于2024-06-14召开股东大会
会议内容 ▼▲
- 1.Election of the eight director nominees named in this Proxy Statement to serve on our Board of Directors until the 2025 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified.
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2024.
3.Approval, on an advisory basis, of the compensation of our named executive officers.
4.Transaction of any other business which may properly come before the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) or any adjournment, continuation or postponement of the Annual Meeting.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益-0.5美元,归母净利润-4145.6万美元,同比去年增长-53.49%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.42美元,归母净利润-3425.2万美元,同比去年增长-45.06%
|
| 2023-04-28 |
股东大会：
将于2023-06-21召开股东大会
会议内容 ▼▲
- 1.Election of the eight director nominees named in this Proxy Statement to serve on our Board of Directors until the 2024 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified. The Executive Committee of the Board of Directors (the “Executive Committee”) on behalf of the Board of Directors recommends a vote “FOR” each nominee.
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2023. The Executive Committee on behalf of the Board of Directors recommends a vote “FOR” this proposal.
3.Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. The Executive Committee on behalf of the Board of Directors recommends a vote for “ONE YEAR” for the frequency of future advisory votes on the compensation of our named executive officers.
4.Transaction of any other business which may properly come before the 2023 Annual Meeting of Stockholders (the “Annual Meeting”) or any adjournment, continuation or postponement of the Annual Meeting. In addition to the business to be transacted as described above, management will speak on our developments over the past year and respond to questions of general interest to stockholders.
|
| 2022-04-29 |
股东大会：
将于2022-06-22召开股东大会
会议内容 ▼▲
- 1.Election of the eight nominees named in this Proxy Statement to serve on our Board of Directors. The Executive Committee on behalf of the Board of Directors recommends a vote “FOR” each nominee.
2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2022. The Executive Committee on behalf of the Board of Directors recommends a vote “FOR” this proposal.
3.Any other business which may properly come before the 2022 Annual Meeting of Stockholders (the “Annual Meeting”) or any adjournment or postponement. In addition to the business to be transacted as described above, management will speak on our developments over the past year and respond to questions of general interest to stockholders.
|